Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

Penumbra, Inc.

PEN Healthcare Unknown Updated July 31, 2026
$321.11
52W $221.26 – $362.41
58/100
$12.63B
78.5
0.70
AI Committee Verdict
Buy
Conviction: Contested · 57% agreement · 7 analysts
+8.0%
-1.9%
4.11:1
Contested

Is PEN Bullish or Bearish?

Bullish. Innellis AI committee rates Penumbra, Inc. (PEN) Buy with a composite score of 58/100 , based on 7 analysts with 57% agreement. Last updated July 31, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +16.61 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -3.39 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Risk Analyst sees a compelling case — low leverage (debt-to-equity 0.02) -- balance sheet can absorb a shock. Value Analyst remains cautious — p/e of 73.5 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • EPS growing 323.6% YoY — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
  • Low leverage (debt-to-equity 0.02) -- balance sheet can absorb a shock — Risk
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
  • News sentiment is positive (+0.33 across 6 articles, 14d) — News
Bear Case
  • P/E of 73.5 is expensive by classic value standards — Value
  • Price-to-book of 8.5x prices in significant intangible value — Value
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of July 31, 2026
Overall Committee Score
58/100
Agreement
57%
Analysts
7
Conviction
Contested
Sector Rank
Top 20%
of 93 Healthcare peers
Value Analyst bearish
40 / 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 73.5 is expensive by classic value standards
Growth Analyst bullish
62 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 323.6% YoY
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst bullish
61 / 100 · High confidence
Price action is constructive -- trend and momentum agree
+ MACD histogram positive -- bullish momentum
Risk Analyst bullish
75 / 100 · Moderate confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.02) -- balance sheet can absorb a shock
Macro Analyst neutral
58 / 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
68 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.33 across 6 articles, 14d)
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 59.9 to 58.4.

Analyst-level changes:
  • Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
  • News Analyst: score 71->68 (-3); +1 bullish signal(s).
  • Portfolio Manager: +2 bearish signal(s).
  • Value Analyst: +1 bearish signal(s).

Comparing 2026-07-30 to 2026-07-31 (1 day apart).

Technical Analysis

RSI (14)
70.3
Overbought
MACD Histogram
0.465
Bullish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Lh Ll
Support
$314.89
Resistance
$346.71
Bollinger %B
1.03
Above Upper Band
Price vs Moving Averages
EMA 9
$319.47 Above
EMA 21
$318.80 Above
EMA 50
$319.95 Above
EMA 200
$312.11 Above

Fundamental Analysis

Valuation
0
Growth
43
Profitability
1
Financial Health
100
Cash Flow
37
Valuation
P/E Ratio 78.5×
P/B Ratio 8.25×
PEG Ratio 11.57
Dividend Yield 0.00%
52W High $362.41
52W Low $221.26
Quality & Growth
ROE 12.4%
ROA 9.7%
Gross Margin 67.8%
Operating Margin 12.4%
Revenue Growth YoY
Debt / Equity 0.14
AI Fundamental Assessment
P/E ratio of 78.5 (rich relative to a 15-40x range); Price-to-book of 8.2x; PEG ratio of 11.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.1%; Return on assets of 0.1%; Net margin of 0.1%; Gross margin of 0.7%; Current ratio of 5.75 (healthy short-term liquidity); Debt-to-equity of 0.14; Free cash flow margin of 0.8% (thin cash generation); Free cash flow per share is positive (5.49); Most recent quarter missed estimates by 19.0%; 2 consecutive earnings misses; EPS growth accelerating (-30.5% -> +7.3% QoQ); Average YoY EPS growth of 2.3%; Analyst estimates falling over recent quarters
Get the Full PEN Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore PEN Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime